What is the appropriate regimen for prescribing oral progesterone (e.g. norethindrone, medroxyprogesterone acetate) to delay a period in a female patient of reproductive age with a regular menstrual cycle and no underlying medical conditions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prescribing Oral Progesterone to Delay Menstruation

For menstrual delay in a reproductive-age woman with regular cycles, prescribe norethindrone acetate 5 mg three times daily, starting 3-5 days before the expected period and continuing until menstruation is desired, at which point withdrawal bleeding will occur 2-3 days after stopping.

Recommended Regimen

  • Norethindrone acetate 5 mg orally three times daily (total 15 mg/day) is the standard regimen for menstrual postponement 1
  • Begin administration 3-5 days before the expected menstrual period to ensure adequate progestogenic effect on the endometrium 1
  • Continue daily without interruption for the duration menstruation needs to be delayed 2
  • Withdrawal bleeding typically occurs 2-3 days after discontinuation of the medication 1

Alternative Progestogen Options

  • Medroxyprogesterone acetate 10 mg three times daily can be used as an alternative, though it has a less favorable metabolic profile than norethindrone 3, 1
  • Norethindrone acetate is preferred over medroxyprogesterone acetate due to superior cardiovascular and metabolic outcomes while maintaining excellent endometrial control 4
  • The relative potency of norethindrone is approximately 10 times that of medroxyprogesterone acetate, which explains the dosing differences 1

Critical Timing Considerations

  • Do not start progesterone after menstruation has already begun—it will not stop active bleeding and may cause irregular spotting 5
  • Starting too early (more than 5 days before expected menses) unnecessarily prolongs exposure without additional benefit 1
  • The medication must be taken at the same time each day to maintain stable progestogenic suppression of endometrial shedding 2

Duration and Safety Limits

  • Limit continuous use to a maximum of 2-3 weeks to minimize thrombotic risk, particularly with higher doses of norethindrone 4
  • Prolonged continuous progestogen use (>6 months) carries increased risk of meningioma and should be avoided for menstrual delay purposes 4
  • For patients with personal or family history of venous thromboembolism, consider alternative strategies or use the lowest effective duration 4

Common Pitfalls to Avoid

  • Never use progestin-only contraceptive pills (0.35 mg norethindrone) for menstrual delay—the dose is far too low to suppress menstruation 6, 2
  • Avoid medroxyprogesterone acetate depot injection for menstrual delay, as its prolonged action makes timing of withdrawal bleeding unpredictable 5
  • Do not prescribe oral micronized progesterone for menstrual delay—its bioavailability is poor and inconsistent, requiring doses of 200-400 mg daily that cause significant sedation and dizziness 7, 8

Patient Counseling Points

  • Inform patients that breakthrough bleeding or spotting may occur despite treatment, particularly if doses are missed 2
  • Advise taking the medication with food if nausea occurs, though this is less common with norethindrone than with oral micronized progesterone 8
  • Warn that menstruation will resume 2-3 days after stopping, so plan discontinuation accordingly 1
  • This is a short-term intervention only—it does not provide contraception and should not be used as a contraceptive method 2

References

Guideline

Lowest Dose of Progesterone for Hormone Replacement Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Second-Line Progestogen Options

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Uses of progesterone in clinical practice.

International journal of fertility and women's medicine, 1999

Related Questions

What are the generic and brand names of oral micronized progesterone formulations?
How should I write a prescription for Prometrium (micronized progesterone) 100 mg for its approved indications?
Can vaginal progesterone (a hormone replacement therapy medication) be transferred to a sexual partner during intimacy in a female patient of reproductive age using it for fertility issues, menstrual regulation, or hormone replacement therapy?
Can a 49-year-old female patient without a uterus take progesterone?
What is the appropriate dosage of progesterone for managing bleeding?
What is the recommended treatment for a patient with lymphangitis after a cat bite, considering potential allergies and immunocompromised conditions?
What is the best antibiotic for a patient with a nail wound, considering potential allergies and underlying health conditions?
What are the recommended treatment options for a patient with osteoarthritis?
What are the treatment options for a female patient of reproductive age with menorrhagia (heavy menstrual bleeding)?
Is administering olanzapine (an atypical antipsychotic) and fluoxetine (Prozac, a selective serotonin reuptake inhibitor) separately as effective as Symbyax (olanzapine and fluoxetine) for a patient with a history of severe depression or bipolar disorder?
What is the diagnosis and management for a 37-year-old female with persistent anxiety, paresthesias in the lower legs, feet, arms, and upper back, facial flushing, memory loss, and cognitive fog, who developed these symptoms 1 month after discontinuing a polypharmacy regimen including Prozac (fluoxetine), Lexapro (escitalopram), Depakote (valproate), Buspar (buspirone), and Adderall (amphetamine and dextroamphetamine), with initial workup showing mildly elevated inflammatory markers and a slightly elevated fasting glucose level?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.